A Systematic Review of Curcumin and Its Derivatives As Valuable Sources of Antileishmanial Agents

Overview

Journal Acta Parasitol

Specialty Parasitology

Date 2021 Mar 26

PMID 33770343

Citations 6

Authors

Aishah E Albalawi

Abdullah D Alanazi

Iraj Sharifi

Fatemeh Ezzatkhah

Affiliations

Soon will be listed here.

Abstract

Background: In recent years, antimonial agents and other synthetic antileishmanial drugs, such as amphotericin B, paromomycin, and many other drugs, have restrictions in use due to the toxicity risk, high cost, and emerging resistance to these drugs. The present study aimed to review the antileishmanial effects of curcumin, its derivatives, and other relevant pharmaceutical formulations on leishmaniasis.

Methods: The present study was carried out according to the 06-preferred reporting items for systematic reviews and meta-analyses (PRISMA) guideline and registered in the CAMARADES-NC3Rs Preclinical Systematic Review and Meta-Analysis Facility (SyRF) database. Some English-language databases including PubMed, Google Scholar, Web of Science, EBSCO, Science Direct, and Scopus were searched for publications worldwide related to antileishmanial effects of curcumin, its derivatives, and other relevant pharmaceutical formulations, without date limitation, to identify all the published articles (in vitro, in vivo, and clinical studies). Keywords included "curcumin", "Curcuma longa", "antileishmanial", "Leishmania", "leishmaniasis", "cutaneous leishmaniasis", "visceral leishmaniasis", "in vitro", and "in vivo".

Results: Out of 5492 papers, 29 papers including 20 in vitro (69.0%), 1 in vivo (3.4%), and 8 in vitro/in vivo (27.6%) studies conducted up to 2020, met the inclusion criteria for discussion in this systematic review. The most common species of the Leishmania parasite used in these studies were L. donovani (n = 13, 44.8%), L. major (n = 10, 34.5%), and L. amazonensis (n = 6, 20.7%), respectively. The most used derivatives in these studies were curcumin (n = 15, 33.3%) and curcuminoids (n = 5, 16.7%), respectively.

Conclusion: In the present review, according to the studies in the literature, various forms of drugs based on curcumin and their derivatives exhibited significant in vitro and in vivo antileishmanial activity against different Leishmania spp. The results revealed that curcumin and its derivatives could be considered as an alternative and complementary source of valuable antileishmanial components against leishmaniasis, which had no significant toxicity. However, further studies are required to elucidate this concluding remark, especially in clinical settings.

Citing Articles

Bioactive Compounds with Leishmanicidal Potential from and .

Napoles Rodriguez R, Arreguez M, Corlatti A, Bach H, Catalan C, Laurella L Molecules. 2025; 30(5).

PMID: 40076264 PMC: 11901713. DOI: 10.3390/molecules30051039.

Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

Soto-Sanchez J, Garza-Trevino G Pharmaceutics. 2024; 16(10).

PMID: 39458571 PMC: 11510106. DOI: 10.3390/pharmaceutics16101239.

Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis.

Clemente C, Murillo J, Garro A, Arbelaez N, Pineda T, Robledo S Parasitol Res. 2024; 123(4):185.

PMID: 38632113 PMC: 11023993. DOI: 10.1007/s00436-024-08199-w.

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review.

Dourado D, Medeiros T, Alencar E, Matos Sales E, Formiga F Beilstein J Nanotechnol. 2024; 15:37-50.

PMID: 38213574 PMC: 10777206. DOI: 10.3762/bjnano.15.4.

Green Synthesis, Characterization, and Antileishmanial Activity of the Silver Nanoparticles Alone and Along with Meglumine Antimoniate against Infection.

Majeed Q, Shater A, Alanazi A Iran J Parasitol. 2024; 18(4):535-545.

PMID: 38169555 PMC: 10758081. DOI: 10.18502/ijpa.v18i4.14262.

References

Alvar J, Velez I, Bern C, Herrero M, Desjeux P, Cano J . Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012; 7(5):e35671. PMC: 3365071. DOI: 10.1371/journal.pone.0035671. View

Mahmoudvand H, Tavakoli R, Sharififar F, Minaie K, Ezatpour B, Jahanbakhsh S . Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone. Pharm Biol. 2014; 53(7):1052-7. DOI: 10.3109/13880209.2014.957784. View

de Vries H, Reedijk S, Schallig H . Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015; 16(2):99-109. PMC: 4363483. DOI: 10.1007/s40257-015-0114-z. View

Sharifi I, Aflatoonian M, Daei Parizi M, Hosseininasab A, Mostafavi M, Bamorovat M . Visceral Leishmaniasis in Southeastern Iran: A Narrative Review. Iran J Parasitol. 2017; 12(1):1-11. PMC: 5522684. View

Mahmoudvand H, Ezzatkhah F, Sharififar F, Sharifi I, Dezaki E . Antileishmanial and cytotoxic effects of essential oil and methanolic extract of Myrtus communis L. Korean J Parasitol. 2015; 53(1):21-7. PMC: 4384785. DOI: 10.3347/kjp.2015.53.1.21. View

Oliaee R, Sharifi I, Afgar A, Kareshk A, Asadi A, Heshmatkhah A . Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling. Trop Med Int Health. 2018; 23(6):622-633. DOI: 10.1111/tmi.13062. View

Ezatpour B, Dezaki E, Mahmoudvand H, Azadpour M, Ezzatkhah F . In Vitro and In Vivo Antileishmanial Effects of Pistacia khinjuk against Leishmania tropica and Leishmania major. Evid Based Complement Alternat Med. 2015; 2015:149707. PMC: 4359887. DOI: 10.1155/2015/149707. View

Gupta S, Patchva S, Koh W, Aggarwal B . Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2011; 39(3):283-99. PMC: 3288651. DOI: 10.1111/j.1440-1681.2011.05648.x. View

Naksuriya O, Okonogi S, Schiffelers R, Hennink W . Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014; 35(10):3365-83. DOI: 10.1016/j.biomaterials.2013.12.090. View

10.

Ghalandarlaki N, Alizadeh A, Ashkani-Esfahani S . Nanotechnology-applied curcumin for different diseases therapy. Biomed Res Int. 2014; 2014:394264. PMC: 4066676. DOI: 10.1155/2014/394264. View

11.

Nafari A, Cheraghipour K, Sepahvand M, Shahrokhi G, Gabal E, Mahmoudvand H . Nanoparticles: New agents toward treatment of leishmaniasis. Parasite Epidemiol Control. 2020; 10:e00156. PMC: 7298521. DOI: 10.1016/j.parepi.2020.e00156. View

12.

Dezaki E, Mahmoudvand H, Sharififar F, Fallahi S, Monzote L, Ezatkhah F . Chemical composition along with anti-leishmanial and cytotoxic activity of Zataria multiflora. Pharm Biol. 2015; 54(5):752-8. DOI: 10.3109/13880209.2015.1079223. View

13.

Chan M, Adapala N, Fong D . Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania. Parasitol Res. 2005; 96(1):49-56. DOI: 10.1007/s00436-005-1323-9. View

14.

Das R, Roy A, Dutta N, Majumder H . Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis. 2008; 13(7):867-82. DOI: 10.1007/s10495-008-0224-7. View

15.

Koide T, Nose M, Ogihara Y, Yabu Y, Ohta N . Leishmanicidal effect of curcumin in vitro. Biol Pharm Bull. 2002; 25(1):131-3. DOI: 10.1248/bpb.25.131. View

16.

Adapala N, Chan M . Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model. Lab Invest. 2008; 88(12):1329-39. PMC: 3056242. DOI: 10.1038/labinvest.2008.90. View

17.

Chaubey P, Patel R, Mishra B . Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opin Drug Deliv. 2014; 11(8):1163-81. DOI: 10.1517/17425247.2014.917076. View

18.

Fouladvand M, Barazesh A, Tahmasebi R . Evaluation of in vitro antileishmanial activity of curcumin and its derivatives "gallium curcumin, indium curcumin and diacethyle curcumin". Eur Rev Med Pharmacol Sci. 2014; 17(24):3306-8. View

19.

Kidwai S, Park C, Mawatwal S, Tiwari P, Jung M, Gosain T . Dual Mechanism of Action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017; 61(11). PMC: 5655107. DOI: 10.1128/AAC.00969-17. View

20.

Chauhan I, Rao G, Shankar J, Chauhan L, Kapadia G, Singh N . Chemoprevention of Leishmaniasis: In-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani. Parasitol Int. 2018; 67(5):627-636. DOI: 10.1016/j.parint.2018.06.004. View